The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, ...

Jehangir Hospital's Pulmonology Department sets new standards in healthcare with cutting-edge diagnostics and personalized ...

Specialty pharmacy expands access to an innovative, steroid-free treatment NEW PROVIDENCE, NJ, UNITED STATES, March 3, 2025 /EINPresswire / -- ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

In addition to cigarette smoke, other chemicals may also raise a nonsmoking woman's risk of developing lung cancer. These compounds may be present in your home or place of employment. Among the ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

During its first 20 weeks on the market, there has been steady growth in the number of unique prescribers, new patient prescriptions ... can re-define the COPD treatment paradigm." ...

Q4 2024 Earnings Call Transcript February 27, 2025 Verona Pharma plc misses on earnings expectations. Reported EPS is $-0.4 ...

Delhi NCR is witnessing a sharp rise in cases of influenza, including swine flu, with many residents experiencing prolonged ...